STIMCELL ENERGETICS INC.
Last · OTC Markets OTCQB$0.28-0.000000001192 (-0.00%)stale · yahoo · 29h ago
MA10MA20MA50
Market cap$5.92M21.1M sh
P/E · TTM-7.0fwd -14.0 · eps -0.04 · loss
Beta46.21vs S&P 500
Div yield—annual · TTM
52w range
$0.18$0.48
Volume100session
Issuer
Legal nameSTIMCELL ENERGETICS INC.
HQUnited States (US)
ListingUS STME
ISINUS15115X2062
SectorHealthcare
IndustryHealthcare Products
SIC3841
CurrencyUSD
Entity registrysec:0001493712
CIK0001493712
Websitewww.sec.gov
Employees1
AddressCell MedX Corp. 1130 West Pender Street V6E 4A4, Vancouver +844 238 2692
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-08-31
From latest 10-K · 2026-08-31
- Going Concern
- Zero Revenue
- Working Capital Deficit
- Related Party Debt
- Dilution Risk
- Regulatory Suspension
- Ineffective Controls
- Ebalance Redesign
Red flags
- Going-concern risk is explicit: cash was $3,057, current liabilities were $1,892,774, working-capital deficit was $1,811,320, and the filing states that these conditions raise substantial doubt about continued operations.
- The Company had no revenue in either FY2026 or FY2025, while net loss increased 58.1% to $895,375 and total operating expenses increased 58.2% to $826,027.
- Related-party loans and advances totaled $833,477 at May 31, 2026, while total amounts due to related parties and notes payable were approximately $1,498,798; $300,582 was borrowed from related parties during the year on demand.
- Debt includes a $30,000 David Jeffs loan and a $30,000 Amir Vahabzadeh note described as in default; most other related-party obligations are unsecured and payable on demand.
- Disclosure controls and internal controls over financial reporting were not effective because of a lack of segregation of duties, and the auditors provided no internal-control attestation report.
- Investor-relations activities of $266,444 were paid through issuance of common shares in FY2026, adding non-cash equity compensation and dilution pressure while the business produced no revenue.
Recent earnings
MON.31AUG
Reported · 9:54 PM UTC+2
Period
Jun 2026
EPS
−$0.01In line0%
Est. revenue
—